LCI News and Press, Lannett Co Inc From 08/19/20

PHILADELPHIA , Aug. 19, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2020 fourth quarter and full year on Wednesday, August 26, 2020 , after the market closes. Lannett management will host a conference ca...

PHILADELPHIA , Aug. 17, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the Notice of Proposed Settlement and Dismissal with Prejudice of Derivative Action (the "Notice"), a copy of which is attached hereto as an Exhibit. Lannett Company entered i...

Lannett Company (NYSE: LCI ) inks an agreement with Respirent Pharmaceuticals Co., Ltd. for exclusive U.S. distribution rights to the latter's generic version of GlaxoSmithKline's (NYSE: GSK ) asthma med Flovent Diskus (Fluticasone Propionate Powder Inhaler). More news on: Lannett Co...

PHILADELPHIA , Aug. 17, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an exclusive U.S. distribution agreement for the therapeutically equivalent generic of Flovent ® Diskus ® (Fluticasone Propionate Powder Inhaler) of Res...

Lannett Company (NYSE: LCI ) launched Cediprof Inc.'s FDA approved Levothyroxine Sodium Tablets USP, under the companies recently announced interim exclusive supply and distribution agreement. More news on: Lannett Company, Inc., Healthcare stocks news, Stocks on the move, Read m...

PHILADELPHIA , Aug. 3, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced the launch of Cediprof, Inc.'s FDA approved Levothyroxine Sodium Tablets USP, under the companies recently announced interim exclusive supply and distribution agreement. The c...

Investment thesis We have gone a full cycle with Lannett ( LCI ) in the past 18 months. We initiated the first position at $6/share, added more shares as the stock short-squeezed to $15/share. Then as the stock fell to $11/share, we trimmed the position as Lannett accounted for 40% of our po...

Lannett (NYSE: LCI ) will soon launch Levorphanol Tablets 2 mg, a partnered product under agreement with U.S. based Novitium Pharma. More news on: Lannett Company, Inc., Healthcare stocks news, Read more ...

PHILADELPHIA , July 27, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will soon launch Levorphanol Tablets 2 mg, a partnered product. Lannett entered into an exclusive U.S. distribution agreement for Levorphanol Tablets with Novitium ...

PHILADELPHIA , July 23, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has launched Mexiletine Hydrochloride Capsules 150 mg, 200 mg and 250 mg, a partnered product. Mexiletine Hydrochloride Capsules is the AB-rated generic equivalent to Mexitil ®...